ST Ningke delays reply to exchange inquiry again

Ningxia Zhongke Biotechnology Co., Ltd. (*ST Ningke) announced another delay in responding to the Shanghai Stock Exchange's inquiry letter (Ref: [2025]0073) concerning its performance forecast. The company stated that the delay is due to the need for further verification and confirmation of issues raised in the inquiry. This marks the second extension, following previous postponements announced on January 25th and February 11th. *ST Ningke assures investors it is actively working to address the inquiry and will disclose information promptly once the response is finalized, while also apologizing for the inconvenience caused by the further delay. The company reminds investors to be cautious and aware of investment risks.